AMIStem-H Radiological Assessment

Medacta International SA500 enrolled

Overview

The purpose of this study is to evaluate radiological performance of the cementless femoral stem AMIStem H at 1 and 5-year follow-up. All the patients operated at the investigational sites between April 2009 and April 2012 will be reviewed at 1, 5 and 10 year according to standard practice

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Hip Replacement Arthroplasty

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients who underwent total hip arthroplasty at the investigational sites between April 2009 and April 2012 * patients bearing an AMIStem-H cementless femoral stem Exclusion Criteria: * patients who refuse to give consent for the treatment of data

Locations (2)

Clinique Paris V

Paris, France, France

Clinique du Cèdre

Bois-Guillaume, France

Outcomes

Primary Outcomes

Presence of radiolucencies

Time frame: 5 years

Secondary Outcomes

correlation between the presence of radiolucencies and patient/implant characteristics

Time frame: 5 years, 10 years

evaluation of radiolucent lines progression

Time frame: 1 years, 10 years

evaluation of radiolucent lines progression

Time frame: 5 years, 10 years

Record of adverse events

Time frame: 1, 5 years and 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.